Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, WWC. Innovative Medicine
-
Stock Symbol
-
JNJ on NYSE
Jennifer L. Taubert - trading volume in the past year for Johnson & Johnson
Holdings reported by Jennifer L. Taubert for Johnson & Johnson
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
155K |
$24.4M |
$157.85 |
Feb 13, 2024 |
Direct |
|
|
| Employee Stock Options (Right to Buy) |
77K |
$6.96M |
$90.44 |
Feb 15, 2024 |
Direct |
Common Stock |
|
| Restricted Share Units |
4.78K |
$755K |
$157.85 |
Feb 15, 2024 |
Direct |
Common Stock |
|
| Performance Share Units |
0 |
$0 |
$157.40 |
Feb 12, 2024 |
Direct |
Common Stock |
|
Transactions reported by Jennifer L. Taubert for Johnson & Johnson
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.